Prognostic Significance of the Pretreatment Neutrophil-to-Lymphocyte Ratio and Tumor-Associated Neutrophils in Head and Neck Squamous Cell Carcinoma: Systematic Review and Meta-Analysis

治疗前中性粒细胞与淋巴细胞比值及肿瘤相关中性粒细胞在头颈部鳞状细胞癌预后中的意义:系统评价和荟萃分析

阅读:1

Abstract

OBJECTIVES: The prognostic significance of the neutrophil-to-lymphocyte ratio (NLR) and tumor-associated neutrophils (TANs) in head and neck squamous cell carcinoma (HNSCC) remains a subject of considerable research interest. This systematic review and meta-analysis aimed to evaluate the relationship between pretreatment NLR and TANs and survival outcomes in patients with HNSCC. METHODS: The systematic literature search was conducted using PubMed, Scopus, Web of Science, and the Cochrane Library. Studies that documented pretreatment NLR in peripheral blood or TANs and their association with disease-specific survival (DSS), progression-free survival (PFS), overall survival (OS), disease-free survival (DFS), and recurrence-free survival (RFS) were included. Meta-analyses were performed using the R "meta" package. Subgroup analyses were performed based on tumor site and NLR thresholds. Heterogeneity was assessed using Cochran's Q and Higgins' I(2) statistics, while publication bias was evaluated using Egger's test and funnel plots. RESULTS: A total of 100 studies comprising 26 324 patients were included. The hazard ratios (HR) for OS, PFS, DFS, DSS, and RFS were 1.88, 1.95, 1.85, 2.16, and 1.11, respectively, in univariate analysis. Multivariate analysis supported these findings and showed similar trends. Subgroup analyses indicated that high NLR consistently predicted poor OS across all studied tumor sites and NLR thresholds. Elevated densities of TANs, particularly CD15(+) and CXCR4(+) subsets, were linked to poorer cancer-specific survival and OS, respectively. CONCLUSION: This meta-analysis indicates that elevated pretreatment NLR, particularly above four, may serve as a significant prognostic marker of poor survival outcomes in patients with HNSCC.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。